Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin R Dosch

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Oncotarget|October 6, 2021
Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancersAustin R Dosch, Walid K Chatila, Yuguang Ban, et al.
Oncotarget|February 26, 2019
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cellsAustin R Dosch, Xizi Dai, Alexander A Gaidarski Iii, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2019
Perioperative blood transfusion is associated with an increased risk for post-surgical infection following pancreaticoduodenectomyAustin R Dosch, Areg Grigorian, Patrick T Delaplain, et al.
Annals of Surgical Oncology|January 11, 2020
Minimally Invasive Surgery is Associated with an Increased Risk of Postoperative Venous Thromboembolism After Distal PancreatectomyBrent A Willobee, Austin R Dosch, Casey J Allen, et al.
Molecular Cancer Research : MCR|January 18, 2020
Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic CancerAustin R Dosch, Xizi Dai, Michelle L Reyzer, et al.
Cancer Research|September 21, 2018
Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic CancerSupriya Srinivasan, Tulasigeri Totiger, Chanjuan Shi, et al.
Molecular Cancer Therapeutics|May 18, 2021
Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal AdenocarcinomaBrent A Willobee, Alexander A Gaidarski, Austin R Dosch, et al.
Molecular Cancer Therapeutics|September 14, 2021
Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic CancerAustin R Dosch, Samara Singh, Xizi Dai, et al.
Cancer Research Communications|July 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic CancerSiddharth Mehra, Vanessa T Garrido, Austin R Dosch, et al.
Diseases of the Colon and Rectum|August 26, 2025
Brave New World: Analysis of Early Clinical Experience with Molecular Sequencing in the Treatment of Rectal CancerJared T Yee, Ahmed A Eltahir, Oluseye K Oduyale, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Oncotarget|October 6, 2021
Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancersAustin R Dosch, Walid K Chatila, Yuguang Ban, et al.
Oncotarget|February 26, 2019
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cellsAustin R Dosch, Xizi Dai, Alexander A Gaidarski Iii, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2019
Perioperative blood transfusion is associated with an increased risk for post-surgical infection following pancreaticoduodenectomyAustin R Dosch, Areg Grigorian, Patrick T Delaplain, et al.
Annals of Surgical Oncology|January 11, 2020
Minimally Invasive Surgery is Associated with an Increased Risk of Postoperative Venous Thromboembolism After Distal PancreatectomyBrent A Willobee, Austin R Dosch, Casey J Allen, et al.
Molecular Cancer Research : MCR|January 18, 2020
Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic CancerAustin R Dosch, Xizi Dai, Michelle L Reyzer, et al.
Cancer Research|September 21, 2018
Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic CancerSupriya Srinivasan, Tulasigeri Totiger, Chanjuan Shi, et al.
Molecular Cancer Therapeutics|May 18, 2021
Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal AdenocarcinomaBrent A Willobee, Alexander A Gaidarski, Austin R Dosch, et al.
Molecular Cancer Therapeutics|September 14, 2021
Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic CancerAustin R Dosch, Samara Singh, Xizi Dai, et al.
Cancer Research Communications|July 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic CancerSiddharth Mehra, Vanessa T Garrido, Austin R Dosch, et al.
Diseases of the Colon and Rectum|August 26, 2025
Brave New World: Analysis of Early Clinical Experience with Molecular Sequencing in the Treatment of Rectal CancerJared T Yee, Ahmed A Eltahir, Oluseye K Oduyale, et al.
Pageof 3